According to ImmunityBio's latest financial reports the company has $0.26 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.10 B | -66.2% |
2021-12-31 | $0.31 B | 230.12% |
2020-12-31 | $96.06 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | -21.87% | ๐บ๐ธ USA |